CRUS vs MRNA · P/E 18, rev $2.00B vs rev $145.0M
Cirrus Logic Inc (CRUS) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Cirrus Logic Inc (CRUS) is a semiconductors company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ.
Latest reported CRUS revenue for 2026-03-28 was $2.00B. Net income was $414.4M. Revenue was up 5.3% from 2025-03-29 to 2026-03-28. CRUS currently screens at market cap $5.52B and trailing P/E 17.9.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
CRUS currently screens at market cap $5.52B and trailing P/E 17.9. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the CRUS and MRNA stock pages for the full models.
Not investment advice.